-
Will miracle HIV drug go on the PBS?
04 Jul 2025 14:16 GMT
… former president of the International AIDS Society. “But that’ … the Foundation for AIDS Research (amfAR), and HIV researchers and … be a difficult process. “ViiV Healthcare spent a long time … formerly the Australian Federation of AIDS Organisations), says it’s …
-
Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention
02 Jul 2025 17:17 GMT
… adolescents at risk of HIV exposure.
GlobalData infectious … alafenamide), as well as ViiV Healthcare’s Apretude (cabotegravir).
… HIV through PrEP and maximising Yeztugo sales.”
The Elton John AIDS … effective prevention technology for HIV transmission”.
In a …
-
Gilead Eyes HIV Market Domination With Twice-Yearly Yeztugo as GSK Trails
02 Jul 2025 04:07 GMT
… Yeztugo could serve targeted populations.
GSK Gears Up for Market Share … U.K. pharma’s HIV joint venture ViiV Healthcare, Apretude sales rose around … sales to contract.
GSK sees things differently. ViiV Chairman David Redfern said …
-
Cost, insurance limits threaten global progress in HIV treatment
02 Jul 2025 03:40 GMT
… patients.
Access to newer HIV therapies remains a major … challenge in the global HIV treatment landscape, largely due … and prevention therapies such as ViiV Healthcare’s Apretude (cabotegravir) … report, Human Immunodeficiency Virus (HIV): Seven-Market (7M) Drug …
-
Twice Yearly HIV Prevention Shot, Yeztugo, May Face Access Hurdles
01 Jul 2025 16:37 GMT
… quest to end the HIV/AIDS epidemic that still costs … a year. By comparison, ViiV charges around $24,000 annually … working closely with insurers, healthcare systems, and pharmacy benefit … has slashed federal support for HIV treatment, prevention, and …
-
HIV prevention: Daily oral versus long-acting injectables
01 Jul 2025 07:50 GMT
… concluded 10th Asia Pacific AIDS and Co-Infections Conference … in protecting us from HIV. It involves injections … tenofovir and emtricitabine) for HIV prevention among cisgender women … July 2022, its manufacturer ViiV Healthcare announced a voluntary license …
-
Integrase Inhibitors Market Set to Witness Significant Growth by 2025-2032 | Gilead Sciences, ViiV Healthcare group
26 Jun 2025 13:56 GMT
… and increasing government healthcare funding targeting HIV treatment expansion.
- … insights is optimizing personalized HIV therapies addressing resistance variations, … Competitive strategies include:
- ViiV Healthcare’s focus on strategic collaborations …
-
GSK (GSK) Gains FDA Approval for Benlysta Autoinjector for Lupus Treatment
28 Jun 2025 16:50 GMT
… five years and above. GSK (GSK) Gains FDA Approval … their caregivers immediately. GSK plc (NYSE:GSK) is a … (asthma), and HIV treatments through its ViiV Healthcare joint venture. While … we acknowledge the potential of GSK …
-
By maintaining Obamacare pillar, Supreme Court hands win to HIV advocates
27 Jun 2025 19:29 GMT
… modest decline recently in HIV cases, and HIV advocates stand at … and uncertainty about Kennedy
HIV advocates expressed concern that … the medical approach to HIV/AIDS in the past, and … as PrEP. In late 2021, ViiV Healthcare’s Apretude — an injection …
-
Sally Gunnell relishing taking part in latest Tackle HIV challenge
27 Jun 2025 03:42 GMT
… in the past around AIDS and HIV, so events like … proved invaluable, according to Viiv Healthcare’s Helen McDowell.
“We … HIV is a campaign led by Gareth Thomas in partnership with ViiV Healthcare … stigma and misunderstanding around HIV. For more information visit …